SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-066978
Filing Date
2014-11-12
Accepted
2014-11-12 11:28:24
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q v392862_10q.htm 10-Q 328414
2 EXHIBIT 31.1 v392862_ex31-1.htm EX-31.1 10084
3 EXHIBIT 31.2 v392862_ex31-2.htm EX-31.2 10238
4 EXHIBIT 32.1 v392862_ex32-1.htm EX-32.1 4869
5 EXHIBIT 32.2 v392862_ex32-2.htm EX-32.2 4931
  Complete submission text file 0001144204-14-066978.txt   4387828

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT antb-20140930.xml EX-101.INS 576868
7 XBRL TAXONOMY EXTENSION SCHEMA antb-20140930.xsd EX-101.SCH 54584
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE antb-20140930_cal.xml EX-101.CAL 35679
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE antb-20140930_def.xml EX-101.DEF 277798
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE antb-20140930_lab.xml EX-101.LAB 363826
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE antb-20140930_pre.xml EX-101.PRE 313942
Mailing Address 1450 INFINITE DRIVE LOUISVILLE CO 80027
Business Address 1450 INFINITE DRIVE LOUISVILLE CO 80027 650-847-1919
AntriaBio, Inc. (Filer) CIK: 0001509261 (see all company filings)

IRS No.: 273440894 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54495 | Film No.: 141212327
SIC: 2834 Pharmaceutical Preparations